Association of non‐alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: A meta‐analysis of observational studies
Open Access
- 29 December 2020
- journal article
- research article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 12 (8) , 1471-1479
Abstract
Aims/Introduction: Non‐alcoholic fatty liver disease (NAFLD) is becoming more and more prevalent in type 2 diabetes mellitus. Evidence connecting NAFLD to diabetic retinopathy (DR) is increasing, but the results vary. Thus, we undertook a meta‐analysis to explore the effect of NAFLD on diabetic retinopathy in patients with type 2 diabetes mellitus.Materials and Methods: PubMed, Embase, Cochrane and Scopus database were searched for until September 30, 2019. Original studies analyzing the association between NAFLD and diabetic retinopathy in the type 2 diabetic population were included. This meta‐analysis was processed by RevMan 5.3 software. Subgroup analyses based on countries were carried out. The pooled odds ratios and 95% confidence intervals were used to evaluate the association between NAFLD and diabetic retinopathy incidence. The I2 test was used to assess heterogeneity of studies.Results: We retrieved 414 articles, and nine studies involving 7,170 patients were included in the final analysis. The pooled effects estimate suggested that NAFLD was not associated with the risk of diabetic retinopathy in patients with type 2 diabetes mellitus. Subgroup analysis suggested that in China, Korea and Iran, patients with type 2 diabetes mellitus with NAFLD had a decreased risk for diabetic retinopathy compared with the non‐NAFLD individuals. However, in Italy and India, patients with type 2 diabetes mellitus with NAFLD had an increased risk for diabetic retinopathy compared with the non‐NAFLD individuals. In addition, no relevance between NAFLD and diabetic retinopathy was found in America.Conclusions: On the whole, there was no association between NAFLD and diabetic retinopathy in individuals with type 2 diabetes mellitus. However, subgroup analysis showed that a difference of country may have an influence on the result.Keywords
This publication has 37 references indexed in Scilit:
- Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid AccumulationEndocrine, Metabolic & Immune Disorders - Drug Targets, 2019
- Associations between nonalcoholic fatty liver disease and ischemic strokeWorld Journal of Hepatology, 2018
- High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistanceJournal of Hepatology, 2018
- Clinical epidemiology and disease burden of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology, 2017
- Opening eyes to nanomedicine: Where we are, challenges and expectations on nanotherapy for diabetic retinopathyNanomedicine: Nanotechnology, Biology and Medicine, 2017
- New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)Protein & Cell, 2017
- Non-alcoholic fatty liver disease and diabetesMetabolism, 2016
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of GastroenterologyGastroenterology, 2012
- An Integrated Approach to Diabetic Retinopathy ResearchArchives of Ophthalmology (1950), 2011
- Diabetic Retinopathy in a Multi-ethnic Cohort in the United StatesAmerican Journal of Ophthalmology, 2006